S. Balachandra

SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study

R. Lunevicius, J. Windsor, Z. Abbas, 2021, Gut.

Hyperlipidaemia and outcome in acute pancreatitis

A. Siriwardena, H. Siriwardana, M. France, 2005, International journal of clinical practice.

SARS- CoV- 2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or long- term of

R. Lunevicius, Z. Abbas, B. Ivanov, 2022 .

Randomised, double blind, placebo controlled trial of intravenous antioxidant (n-acetylcysteine, selenium, vitamin C) therapy in severe acute pancreatitis

A. Siriwardena, L. Formela, J. Hardman, 2007, Gut.

Systematic appraisal of the management of the major vascular complications of pancreatitis.

A. Siriwardena, S. Balachandra, 2005, American journal of surgery.

the real costs of treating early post-operative leaks following sleeve gastrectomy procedures : p26

A. Ahmed, M. Adamo, S. Balachandra, 2015 .

Inhibition of tyrosine-kinase-mediated cellular signaling by tyrphostins AG 126 and AG556 modulates murine experimental acute pancreatitis.

E. Mazzon, S. Cuzzocrea, T. Genovese, 2005, Surgery.

SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study

R. Lunevicius, J. Windsor, Z. Abbas, 2021, Gut.